Illumina Ventures
Overview
Illumina Ventures visions is to improve human health by unlocking the power of the genome.
Investment Focus
- Early-stage companies developing breakthrough science and technologies in life sciences tools, therapeutics, diagnostics, and personal wellness.
Portfolio Companies
Get the full list of 54,000+ investors
Illumina Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Illumina Ventures
What sectors does Illumina Ventures invest in?
Illumina Ventures invests in Healthcare, Life Sciences, Diagnostics, Biotechnology, Synthetic Biology and Therapeutics, and is based in San Francisco, California, United States. Illumina Ventures is listed as a vc in the ConnectSafely investor database.
What stage does Illumina Ventures invest at?
Illumina Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage.
Which regions does Illumina Ventures invest in?
Illumina Ventures invests across United States, United Kingdom and Ireland.
Who are the partners at Illumina Ventures?
Team members listed for Illumina Ventures include Rose Lai (EA to Founder and Office Manager) and Donal Delaney (Chief Financial Officer).
What companies has Illumina Ventures invested in?
Illumina Ventures's portfolio includes Arbor Biotechnologies, RedShiftBio and Fluent Biosciences.
How do I contact Illumina Ventures?
Illumina Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
